Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections

Parasitology

Volumn 123, Issue 6, 2001, Pages 537-546

  Gatton, M L ^a   Hogarth, W ^b   Saul, A ^c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antibodies; Drug resistance; Malaria; Mathematical modelling; PfEMP1; Plasmodium falciparum

Indexed keywords

PROTEIN PFEMP1; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; GENE SWITCHING; HOST; MALARIA; MATHEMATICAL MODEL; MUTATION RATE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; ATOVAQUONE; COMPUTER SIMULATION; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; MUTATION; NAPHTHOQUINONES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PYRIMETHAMINE; TIME FACTORS;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035691418     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182001008824     Document Type: Article

References (27)

1. Mass treatment with pyrimethamine: A study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya
2. Pre-existence and emergence of drug resistance in HIV-1 infection
3. Malaria parasites undergo antigenic variation at high rates in vivo
4. The development of pyrimethamine resistance by Plasmodium falciparum
5. Resistance of east African varieties of Plasmodium falciparum to pyrimethamine
6. Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs
7. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali
8. Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis
9. Variant antigens and endothelial receptor adhesion in Plasmodium falciparum
10. Seasonal variation in agglutination of Plasmodium falciparum-infected erythrocytes
11. An analysis of the temperature effects of fever on the intra-host population dynamics of Plasmodium falciparum
12. Invasion thresholds for fungicide resistance: Deterministic and stochastic analyses
13. A model for the origins and spread of drug-resistant malaria
14. The emergence of drug-resistant malaria
15. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site
16. The population dynamics of antimicrobial chemotherapy
17. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand
18. Survival probability of drug resistant mutants in malaria parasites
19. The use of medicated salt in an antimalaria campaign in west New Guinea
20. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum
21. Describing recrudescence patterns and switching rates in Plasmodium falciparum infections by mathematical modelling
22. Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum
23. The frequency of resistant mutant virus before antiviral therapy
24. The role of variant surface antigens on malaria-infected red blood cells
25. Mefloquine pharmacokinetic-pharmacodynamic models: Implications for dosing and resistance
26. Why is it that antimalarial drug treatments do not always work?
27. Antimalarial drug resistance and combination chemotherapy